AlphaClone, a provider of alpha-seeking active indexes for long-term investors, has launched the AlphaClone Small Cap Index and AlphaClone Value Manager Index.

The indices seek to give investors the potential to outperform passive market indices by accessing the investment ideas of the world’s most established hedge funds.
 
They follow the same proprietary Clone Score methodology used by AlphaClone’s Hedge Fund Downside Hedged Index and AlphaClone’s International Downside Hedged Index.
 
Last year, the firm filed with the Securities and Exchange Commission to register four new exchange-traded funds (ETFs).
 
“Pursuing the potential for alpha is even more important today for long-term investors, given the anaemic growth forecasted for equities and bonds over the next several years,” says Maz Jadallah (pictured), CEO of AlphaClone. “We’re delighted to focus our investment methodology to new segments of the equity investment world, further expanding our active indexing approach for global investors.”
 
The AlphaClone Small Cap Index tracks the performance of US-traded small capitalisation equity securities to which hedge funds and institutional investors have disclosed significant exposure.
 
The AlphaClone Value Manager Index tracks the performance of US-traded equity securities to which value-oriented hedge funds and institutional investors have disclosed significant exposure.
 
The proprietary index methodology developed by AlphaClone ranks hedge funds and institutional investors who pursue a value investing approach based on the efficacy of replicating their publicity disclosed positions.
 
“Having seen success with our methodology inside separately managed accounts over the past five years, we’re excited to further expand access to our innovative investment methodology and are committed to helping long-term investors succeed,” Jadallah says.